T. Hara

发表

In vivo gene delivery to the liver using reconstituted chylomicron remnants as a novel nonviral vector.

Y. Tan, L. Huang, T. Hara, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Receptor-mediated transfer of pSV2CAT DNA to a human hepatoblastoma cell line HepG2 using asialofetuin-labeled cationic liposomes.

K. Koike, Y. Aramaki, S. Tsuchiya, 1995, Gene.

Emulsion formulations as a vector for gene delivery in vitro and in vivo

Dexi Liu, Leaf Huang, F. Liu, 1997 .

Recognition of charged liposomes by rat peritoneal and splenic macrophages: effects of fibronectin on the uptake of charged liposomes

Y. Aramaki, S. Tsuchiya, K. Akiyama, 1995 .

Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes.

K. Koike, Y. Aramaki, S. Tsuchiya, 1996, Biochimica et biophysica acta.

Receptor-mediated transfer of pSV2CAT DNA to mouse liver cells using asialofetuin-labeled liposomes.

K. Koike, Y. Aramaki, S. Tsuchiya, 1995, Gene therapy.

Preparation of EGF labeled liposomes and their uptake by hepatocytes.

Y. Aramaki, S. Tsuchiya, T. Hara, 1989, Biochemical and biophysical research communications.

Specific uptake of asialofetuin-tacked liposomes encapsulating interferon-gamma by human hepatoma cells and its inhibitory effect on hepatitis B virus replication.

K. Koike, Y. Aramaki, S. Tsuchiya, 1991, Biochemical and biophysical research communications.

Preparation and disposition of asialofetuin-labelled liposome.

Y. Aramaki, S. Tsuchiya, T. Hara, 1986, Biopharmaceutics & drug disposition.

Specific incorporation of asialofetuin-labeled liposomes into hepatocytes through the action of galactose-binding protein.

Y. Aramaki, S. Tsuchiya, T. Hara, 1987, Biopharmaceutics & drug disposition.

Liposomal Induction of a Heat-stable Macrophage Priming Factor to Induce Nitric Oxide in Response to LPS

H. Arima, Y. Aramaki, S. Tsuchiya, 1996, Pharmaceutical Research.

Efficient gene transfer to EGF receptor overexpressing cancer cells by means of EGF-labeled cationic liposomes.

H. Arima, Y. Aramaki, S. Tsuchiya, 1996, Biochemical and biophysical research communications.

Free radicals from 1-palmitoyl-2-arachidonoylphosphatidylcholine liposomes in Fe2+/ascorbic acid solution.

H. Utsumi, Y. Aramaki, S. Tsuchiya, 1996, Biological and Pharmaceutical Bulletin.

Stability of Liposomes in Vitro and Their Uptake by Rat Peyer's Patches Following Oral Administration

Y. Aramaki, S. Tsuchiya, H. Kikuchi, 1993, Pharmaceutical Research.

Characteristics of the binding of asialofetuin-labeled liposomes to isolated rat hepatocytes

Y. Aramaki, S. Tsuchiya, T. Hara, 1991 .

Enhancement of systemic and mucosal immune responses following oral administration of liposomes.

Y. Aramaki, S. Tsuchiya, T. Hara, 1993, Immunology letters.

Receptor‐Mediated Gene Transfer into Hepatic Cells Using Asialoglycoprotein‐Labeled Liposomes

K. Koike, Y. Aramaki, S. Tsuchiya, 1994, Annals of the New York Academy of Sciences.

Interaction of Recombinant Human Interferon-γ with Liposomes

Y. Aramaki, S. Tsuchiya, T. Hara, 1991 .

Preparation of Asialofetuin-Labeled Liposomes with Encapsulated Human Interferon-γ and Their Uptake by Isolated Rat Hepatocytes

Y. Aramaki, S. Tsuchiya, T. Hara, 1990, Pharmaceutical Research.